Highlights Zimmer Biomet Holdings, Inc.

Equities

ZBH

US98956P1021

Real-time Estimate Cboe BZX Other stock markets 09:56:38 2024-06-10 am EDT			5-day change	1st Jan Change
112.4 ^USD	-0.79%		-1.33%	-8.28%

Jun. 05	Osteal Therapeutics, Inc. announced that it has received $50 million in funding from Zimmer Biomet Holdings, Inc., Johnson & Johnson Innovation - JJDC, Inc., HM Capital Management, LLC, GIDEON STRATEGIC PARTNERS LLC and other investors	CI
Jun. 04	Zimmer Biomet Holdings Insider Sold Shares Worth $1,474,582, According to a Recent SEC Filing	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zimmer Biomet's Limited Exposure to High-Growth Markets Spurs Revenue Concerns, UBS Says	May. 31	MT
Zimmer Biomet Outlines Growth Strategy Through 2027; Board Approves $2 Billion Stock Buyback	May. 29	MT
Zimmer Biomet Holdings, Inc. announces an Equity Buyback for $2,000 million worth of its shares.	May. 29	CI
Zimmer Biomet Holdings, Inc. authorizes a Buyback Plan.	May. 28	CI
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024, Payable on or About July 31, 2024	May. 13	CI
Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices	May. 02	RE
Zimmer Biomet Holdings Q1 Adjusted Earnings, Net Sales Rise; 2024 Outlook Reiterated	May. 02	MT
(ZBH) ZIMMER BIOMET HOLDINGS Expects Fiscal Year 2024 EPS Range $8.00 - $8.15	May. 02	MT
Earnings Flash (ZBH) ZIMMER BIOMET HOLDINGS Reports Q1 Revenue $1.89B, vs. Street Est of $1.87B	May. 02	MT
Earnings Flash (ZBH) ZIMMER BIOMET HOLDINGS Posts Q1 EPS $1.94, vs. Street Est of $1.87	May. 02	MT
Zimmer Biomet Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02	CI
Zimmer Biomet Holdings, Inc. Reiterates Financial Guidance for Current Full-Year 2024	May. 02	CI
Zimmer Biomet Partners with Three Pickleball Organizations in US	Apr. 04	MT
Ex-dividend day	Mar. 26	FA
3M Board Approves Healthcare Unit Spinoff -- Update	Mar. 08	DJ
Zimmer Biomet's ROSA Shoulder Replacement Platform Receives FDA Clearance	Feb. 22	MT
Zimmer Biomet Holdings, Inc. Announces U.S. Food and Drug Administration 510(K) Clearance of the Rosa® Shoulder System for Robotic-Assisted Shoulder Replacement Surgery	Feb. 22	CI
Zimmer Biomet Maintains Quarterly Dividend at $0.24 a Share, Payable by April 30 to Shareholders of Record March 29	Feb. 21	MT
Zimmer Biomet Holdings, Inc. Announces Quarterly Cash Dividend for the First Quarter of 2024, Payable on or About April 30, 2024	Feb. 21	CI
Zimmer Biomet Holdings, Inc. Showcases Latest Innovations Across Comprehensive Portfolio at AAOS 2024 Annual Meeting	Feb. 12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Zimmer Biomet Holdings, Inc.

Equities

ZBH

US98956P1021

Highlights

Filters